Outcomes of Maximal Conventional Therapy Before Biological Treatment in Recurrent Chronic Rhinosinusitis With Nasal Polyps

Topan YE, Bayar Muluk N, Yavuz R, Alataş N, Cingi C

J Craniofac Surg · 2026

Grade Ccohortn=42

Key Findings

  • MCT improved SNOT-22 in ~70% of recurrent CRSwNP patients after prior ESS
  • Only 13% of patients required biologics after structured MCT protocol
  • Structured pre-biologic evaluation can identify true biologic candidates

Referenced in (1 disease)

ID: pmid-41842750DOI: 10.1097/SCS.0000000000012616PMID: 41842750